Suppr超能文献

乳糜泻中小肠组织转谷氨酰胺酶的表达及酶活性

Expression and enzymatic activity of small intestinal tissue transglutaminase in celiac disease.

作者信息

Esposito Carla, Paparo Francesco, Caputo Ivana, Porta Raffaele, Salvati Virginia M, Mazzarella Giuseppe, Auricchio Salvatore, Troncone Riccardo

机构信息

Department of Chemistry, University of Salerno, Salerno, Italy.

出版信息

Am J Gastroenterol. 2003 Aug;98(8):1813-20. doi: 10.1111/j.1572-0241.2003.07582.x.

Abstract

OBJECTIVES

The molecular and functional properties of small intestinal tissue transglutaminase are largely unknown despite growing interest because of its role in celiac disease (CD). In this study, we aimed to evaluate tissue transglutaminase expression and enzymatic activity in bioptic fragments obtained from the duodenum of untreated individuals with CD and from control subjects.

METHODS

Analysis of tissue transglutaminase mRNA expression was performed by reverse transcription-polymerase chain reaction (RT-PCR). The presence of the enzyme in bioptic fragments as well as in homogenates from CD patients and controls was revealed by immunohistochemistry and Western blot, respectively, using the antitissue transglutaminase CUB 7402 clone. To evaluate in situ transglutaminase activity, sections of bioptic fragments were incubated in the presence of 5 mmol/L CaCl(2) with 5-(biotinamido)pentylamine or, alternatively, with a biotinylated glutamine-containing hexapeptide (TVQQEL) and the biotinylated 31-43 A-gliadin-derived peptide.

RESULTS

Tissue transglutaminase mRNA levels were 1.0-fold higher (p < 0.05) in CD patients than in controls. Immunohistochemistry and in situ demonstration of enzymatic activity in celiac mucosa clearly showed an increased expression of active tissue transglutaminase in the extracellular matrix of the subepithelial region and in the enterocytes. Staining of the biotinylated 31-43 A-gliadin peptide in the same area of tissue transglutaminase suggested the presence of lysine-donor substrates in intestinal mucosa.

CONCLUSIONS

Tissue transglutaminase is more expressed and active in defined areas of the small intestinal mucosa from patients with CD. The presence in the celiac mucosa of proteins able to act as amine-donor substrates suggests that tissue transglutaminase-mediated post-translational modification of proteins cross-linked with gliadin peptides may represent a pathogenic mechanism of CD.

摘要

目的

尽管小肠组织转谷氨酰胺酶因其在乳糜泻(CD)中的作用而受到越来越多的关注,但其分子和功能特性在很大程度上仍不清楚。在本研究中,我们旨在评估从未经治疗的CD患者十二指肠以及对照受试者获取的活检组织片段中转谷氨酰胺酶的表达和酶活性。

方法

通过逆转录聚合酶链反应(RT-PCR)分析组织转谷氨酰胺酶mRNA的表达。分别使用抗组织转谷氨酰胺酶CUB 7402克隆,通过免疫组织化学和蛋白质印迹法揭示活检组织片段以及CD患者和对照者匀浆中该酶的存在情况。为评估原位转谷氨酰胺酶活性,将活检组织片段切片在5 mmol/L氯化钙存在的情况下与5-(生物素酰胺基)戊胺一起孵育,或者与生物素化的含谷氨酰胺六肽(TVQQEL)以及生物素化的31-43 A-麦醇溶蛋白衍生肽一起孵育。

结果

CD患者的组织转谷氨酰胺酶mRNA水平比对照者高1.0倍(p < 0.05)。免疫组织化学以及在乳糜泻黏膜中酶活性的原位显示清楚地表明,活性组织转谷氨酰胺酶在上皮下区域的细胞外基质和肠细胞中的表达增加。在组织转谷氨酰胺酶相同区域对生物素化的31-43 A-麦醇溶蛋白肽进行染色表明,肠黏膜中存在赖氨酸供体底物。

结论

组织转谷氨酰胺酶在CD患者小肠黏膜的特定区域表达更高且活性更强。乳糜泻黏膜中存在能够作为胺供体底物的蛋白质表明,组织转谷氨酰胺酶介导的与麦醇溶蛋白肽交联的蛋白质翻译后修饰可能代表了CD的一种致病机制。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验